Women’s Sex Drives
Welcome back from Thanksgiving to all you American readers! If you’re feeling as groggy and full of turkey as I am, a little sex drive talk is just what you need to wake up this Monday morning. The US Food & Drug Administration is considering a female version of Viagra called Flibanserin to treat women with hypoactive sexual desire disorder, or a severe lack of a sex drive. (You may be surprised to learn that Viagra generated sales of $1.8 billion in the US alone last year). Created at the Boehringer Ingelheim in Germany, the drug has already done well in clinical trials in North America and Europe.
As with any new medicine, major concerns persist about side and long-term effects. In 2004 the FDA did not approve a testosterone patch for women, Intrinsa, due to safety concerns. Researchers in the UK and Australia reported in the October edition of the Journal of Sexual Medicine that dissatisfaction in bed can spread to other aspect’s of a woman’s life, so some women may take the risk in search of the ultimate satisfaction. (Was this really unknown before this article was published?) Read about the drug and its history here.
Interestingly, the New York Times published an article in the magazine yesterday about hypoactive sexual desire disorder. Very little is known about this disorder (which some don’t even consider a disorder), so it makes for an interesting read. Are you awake yet? Have a good Monday!